Sodium alginate swollen microneedle patch and preparation method thereof
A technology of sodium alginate and microneedle paste, which is applied in the direction of microneedles, needles, and pharmaceutical formulations, and can solve the problem of continuous limitation of diffusion channels for large-dose administration, poor biocompatibility of human protein, and the impact of embedded protein properties, etc. problems, to achieve excellent physiological inertia, excellent biocompatibility, and protect the effect of protein activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The sodium alginate swelling microneedle patch provided in this embodiment has a specific technical scheme as follows:
[0026] Sodium alginate swollen microneedle patches, such as figure 2 As shown, it includes a needle body and a microneedle substrate, and the needle body array is distributed on the microneedle substrate and integrally formed with the microneedle substrate. The needle body includes sodium alginate and polyvinylpyrrolidone, and the composition ratio is 6:1 in terms of weight percentage. The pitch of the needles is 600 μm, and the vertical height of the needles is 200 μm. The needle body is a tapered structure, and the taper of the needle body is 70°.
[0027] This embodiment provides the above-mentioned method for swelling the microneedle patch with sodium alginate, comprising the following steps:
[0028] S1, using silicon microneedles with a height of 200 μm and a needle spacing of 600 μm as a mold, pouring a mixture of polydimethylsiloxane and c...
Embodiment 2
[0033] The sodium alginate swelling microneedle patch provided in this embodiment has a specific technical scheme as follows:
[0034] Sodium alginate swollen microneedle patches, such as image 3 As shown, it includes a needle body and a microneedle substrate, and the needle body array is distributed on the microneedle substrate and integrally formed with the microneedle substrate. The needle body includes sodium alginate and polyvinylpyrrolidone, and the composition ratio is 6:1 in terms of weight percentage. The pitch of the needles is 800 μm, and the vertical height of the needles is 450 μm. The needle body is a tapered structure, and the taper of the needle body is 80°.
[0035] This embodiment provides the above-mentioned method for swelling the microneedle patch with sodium alginate, comprising the following steps:
[0036] S1, using silicon microneedles with a height of 450 μm and a needle spacing of 800 μm as a mold, pouring a mixture of polydimethylsiloxane and cu...
Embodiment 3
[0041] The sodium alginate swelling microneedle patch provided in this embodiment has a specific technical scheme as follows:
[0042] The sodium alginate swollen microneedle patch includes a needle body and a microneedle substrate, and the needle body array is distributed on the microneedle substrate and integrally formed with the microneedle substrate. The needle body includes sodium alginate and polyvinylpyrrolidone, and the composition ratio is 5:1 in terms of weight percentage. The pitch of the needles is 700 μm, and the vertical height of the needles is 800 μm. The needle body is a tapered structure, and the taper of the needle body is 70°.
[0043] This embodiment provides the above-mentioned method for swelling the microneedle patch with sodium alginate, comprising the following steps:
[0044]S1, using silicon microneedles with a height of 800 μm and a needle spacing of 700 μm as a mold, pouring a mixture of polydimethylsiloxane and curing agent at a ratio of 10:1, ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| height | aaaaa | aaaaa |
| height | aaaaa | aaaaa |
| height | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


